Please enable JavaScript to continue using this application.

Compare $FENC vs $SRZN | Chartloom

Compare

$FENC vs $SRZN

Fennec Pharmaceuticals Inc · Surrozen Inc

FENC

Fennec Pharmaceuticals Inc

SRZN

Surrozen Inc

Compare $FENC vs $SRZN

Comparing Fennec Pharmaceuticals Inc and Surrozen Inc

FENCFennec Pharmaceuticals Inc

SRZNSurrozen Inc

FENCFennec Pharmaceuticals Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

18.55x

Forward P/S (NTM)

4.23x

Rev growth (TTM)

77.8%

YTD performance

39.5%

52W performance

16.2%

FCF yield

-0.5%

SRZNSurrozen Inc

Market cap

$345M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

118.58x

Rev growth (TTM)

-8.8%

YTD performance

37.8%

52W performance

111.5%

FCF yield

-10.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FENC

SRZN

Detailed metrics comparison

FENC

Fennec Pharmaceuticals Inc

SRZN

Surrozen Inc

Market Cap

FENC$372M

SRZN$345M

Enterprise Value

FENC$331M

SRZN$243M

Price

FENC$10.71

SRZN$29.69

P/E Ratio

FENCN/A

SRZNN/A

P/S Ratio

FENC6.28x

SRZN29.95x

EV/Sales

FENC5.59x

SRZN21.08x

EV/EBITDA

FENC111.97x

SRZN0.00x

P/B Ratio

FENC8.43x

SRZN7.31x

P/FCF Ratio

FENCN/A

SRZNN/A

EV/FCF

FENC-162.16x

SRZN-6.94x

PEG Ratio

FENCN/A

SRZNN/A

Forward P/E (NTM)

FENC18.55x

SRZNN/A

Forward P/S (NTM)

FENC4.23x

SRZN118.58x

Revenue (TTM)

FENC$59M

SRZN$12M

Revenue Growth (YoY)

FENC77.8%

SRZN-8.8%

Forward Rev Growth

FENC42.8%

SRZN-82.6%

Gross Margin (TTM)

FENC93.7%

SRZN0.0%

Operating Margin (TTM)

FENC0.0%

SRZN0.0%

EBITDA Margin (TTM)

FENC-1.9%

SRZN-383.4%

Net Margin (TTM)

FENC-5.5%

SRZN-2885.3%

FCF Margin (TTM)

FENC-3.4%

SRZN-303.9%

Net Income (TTM)

FENC$-3M

SRZN$-332M

FCF (TTM)

FENC$-2M

SRZN$-35M

EPS (TTM)

FENC-$0.09

SRZN-$28.48

ROE (TTM)

FENC-678.0%

SRZN58.2%

ROA (TTM)

FENC-486.0%

SRZN-30962.0%

ROIC (TTM)

FENC-678.0%

SRZN58.2%

Cash

FENC$41M

SRZN$102M

Debt

FENC$0

SRZN$0

Net Cash/Debt

FENC$41M

SRZN$102M

Current Ratio (TTM)

FENC5.85x

SRZN12.14x

Quick Ratio (TTM)

FENC5.36x

SRZN11.88x

Debt/Equity (TTM)

FENC0.00x

SRZN0.00x

Debt/Assets (TTM)

FENC0.0%

SRZN0.0%

Interest Coverage (TTM)

FENCN/A

SRZNN/A

Net Debt/EBITDA (TTM)

FENC0.00x

SRZN0.00x

Beta

FENC1.21

SRZN0.53

52W Performance

FENC16.2%

SRZN111.5%

YTD Performance

FENC39.5%

SRZN37.8%

% from 52W High

FENC-19.2%

SRZN-21.5%

% from 52W Low

FENC89.6%

SRZN160.7%

Asset Turnover (TTM)

FENC0.89x

SRZN0.11x

FCF Yield (TTM)

FENC-0.5%

SRZN-10.1%

Earnings Yield (TTM)

FENC-0.9%

SRZN-96.4%

Dividend Yield (TTM)

FENCN/A

SRZNN/A

Rule of 40

FENC74.4

SRZN-312.7

EV/GP/RG

FENC0.12

SRZNN/A

Ticker research

View FENC research View SRZN research

Metric	FENC Fennec Pharmaceuticals Inc	SRZN Surrozen Inc
Market & Valuation
Market Cap	$372M	$345M
Enterprise Value	$331M	$243M
Price	$10.71	$29.69
P/E Ratio	N/A	N/A
P/S Ratio	6.28x	29.95x
EV/Sales	5.59x	21.08x
EV/EBITDA	111.97x	0.00x
P/B Ratio	8.43x	7.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-162.16x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	18.55x	N/A
Forward P/S (NTM)	4.23x	118.58x
Revenue & Growth
Revenue (TTM)	$59M	$12M
Revenue Growth (YoY)	77.8%	-8.8%
Forward Rev Growth	42.8%	-82.6%
Profitability
Gross Margin (TTM)	93.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-383.4%
Net Margin (TTM)	-5.5%	-2885.3%
FCF Margin (TTM)	-3.4%	-303.9%
Net Income (TTM)	$-3M	$-332M
FCF (TTM)	$-2M	$-35M
EPS (TTM)	-$0.09	-$28.48
ROE (TTM)	-678.0%	58.2%
ROA (TTM)	-486.0%	-30962.0%
ROIC (TTM)	-678.0%	58.2%
Financial Health
Cash	$41M	$102M
Debt	$0	$0
Net Cash/Debt	$41M	$102M
Current Ratio (TTM)	5.85x	12.14x
Quick Ratio (TTM)	5.36x	11.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.53
52W Performance	16.2%	111.5%
YTD Performance	39.5%	37.8%
% from 52W High	-19.2%	-21.5%
% from 52W Low	89.6%	160.7%
Efficiency & Yields
Asset Turnover (TTM)	0.89x	0.11x
FCF Yield (TTM)	-0.5%	-10.1%
Earnings Yield (TTM)	-0.9%	-96.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	74.4	-312.7
EV/GP/RG	0.12	N/A
Ticker research	View FENC research	View SRZN research

Valuation

P/S Ratio

FENC

6.28x

SRZN

29.95x

EV/FCF

FENC

-162.16x

SRZN

-6.94x

Growth & revenue

Revenue Growth TTM

FENC

77.8%

SRZN

-8.8%

Forward Revenue Growth

FENC

42.8%

SRZN

-82.6%

Profitability & performance

Gross Margin

FENC

93.7%

SRZN

0.0%

ROE

SRZN

58.2%

FENC

-678.0%

FCF Yield %

FENC

-0.5%

SRZN

-10.1%

52-Week Performance

SRZN

111.5%

FENC

16.2%

Detailed metrics comparison

FENC

Fennec Pharmaceuticals Inc

SRZN

Surrozen Inc

Market Cap

FENC$372M

SRZN$345M

Enterprise Value

FENC$331M

SRZN$243M

Price

FENC$10.71

SRZN$29.69

P/E Ratio

FENCN/A

SRZNN/A

P/S Ratio

FENC6.28x

SRZN29.95x

EV/Sales

FENC5.59x

SRZN21.08x

EV/EBITDA

FENC111.97x

SRZN0.00x

P/B Ratio

FENC8.43x

SRZN7.31x

P/FCF Ratio

FENCN/A

SRZNN/A

EV/FCF

FENC-162.16x

SRZN-6.94x

PEG Ratio

FENCN/A

SRZNN/A

Forward P/E (NTM)

FENC18.55x

SRZNN/A

Forward P/S (NTM)

FENC4.23x

SRZN118.58x

Revenue (TTM)

FENC$59M

SRZN$12M

Revenue Growth (YoY)

FENC77.8%

SRZN-8.8%

Forward Rev Growth

FENC42.8%

SRZN-82.6%

Gross Margin (TTM)

FENC93.7%

SRZN0.0%

Operating Margin (TTM)

FENC0.0%

SRZN0.0%

EBITDA Margin (TTM)

FENC-1.9%

SRZN-383.4%

Net Margin (TTM)

FENC-5.5%

SRZN-2885.3%

FCF Margin (TTM)

FENC-3.4%

SRZN-303.9%

Net Income (TTM)

FENC$-3M

SRZN$-332M

FCF (TTM)

FENC$-2M

SRZN$-35M

EPS (TTM)

FENC-$0.09

SRZN-$28.48

ROE (TTM)

FENC-678.0%

SRZN58.2%

ROA (TTM)

FENC-486.0%

SRZN-30962.0%

ROIC (TTM)

FENC-678.0%

SRZN58.2%

Cash

FENC$41M

SRZN$102M

Debt

FENC$0

SRZN$0

Net Cash/Debt

FENC$41M

SRZN$102M

Current Ratio (TTM)

FENC5.85x

SRZN12.14x

Quick Ratio (TTM)

FENC5.36x

SRZN11.88x

Debt/Equity (TTM)

FENC0.00x

SRZN0.00x

Debt/Assets (TTM)

FENC0.0%

SRZN0.0%

Interest Coverage (TTM)

FENCN/A

SRZNN/A

Net Debt/EBITDA (TTM)

FENC0.00x

SRZN0.00x

Beta

FENC1.21

SRZN0.53

52W Performance

FENC16.2%

SRZN111.5%

YTD Performance

FENC39.5%

SRZN37.8%

% from 52W High

FENC-19.2%

SRZN-21.5%

% from 52W Low

FENC89.6%

SRZN160.7%

Asset Turnover (TTM)

FENC0.89x

SRZN0.11x

FCF Yield (TTM)

FENC-0.5%

SRZN-10.1%

Earnings Yield (TTM)

FENC-0.9%

SRZN-96.4%

Dividend Yield (TTM)

FENCN/A

SRZNN/A

Rule of 40

FENC74.4

SRZN-312.7

EV/GP/RG

FENC0.12

SRZNN/A

Ticker research

View FENC research View SRZN research

Metric	FENC Fennec Pharmaceuticals Inc	SRZN Surrozen Inc
Market & Valuation
Market Cap	$372M	$345M
Enterprise Value	$331M	$243M
Price	$10.71	$29.69
P/E Ratio	N/A	N/A
P/S Ratio	6.28x	29.95x
EV/Sales	5.59x	21.08x
EV/EBITDA	111.97x	0.00x
P/B Ratio	8.43x	7.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-162.16x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	18.55x	N/A
Forward P/S (NTM)	4.23x	118.58x
Revenue & Growth
Revenue (TTM)	$59M	$12M
Revenue Growth (YoY)	77.8%	-8.8%
Forward Rev Growth	42.8%	-82.6%
Profitability
Gross Margin (TTM)	93.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-383.4%
Net Margin (TTM)	-5.5%	-2885.3%
FCF Margin (TTM)	-3.4%	-303.9%
Net Income (TTM)	$-3M	$-332M
FCF (TTM)	$-2M	$-35M
EPS (TTM)	-$0.09	-$28.48
ROE (TTM)	-678.0%	58.2%
ROA (TTM)	-486.0%	-30962.0%
ROIC (TTM)	-678.0%	58.2%
Financial Health
Cash	$41M	$102M
Debt	$0	$0
Net Cash/Debt	$41M	$102M
Current Ratio (TTM)	5.85x	12.14x
Quick Ratio (TTM)	5.36x	11.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.53
52W Performance	16.2%	111.5%
YTD Performance	39.5%	37.8%
% from 52W High	-19.2%	-21.5%
% from 52W Low	89.6%	160.7%
Efficiency & Yields
Asset Turnover (TTM)	0.89x	0.11x
FCF Yield (TTM)	-0.5%	-10.1%
Earnings Yield (TTM)	-0.9%	-96.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	74.4	-312.7
EV/GP/RG	0.12	N/A
Ticker research	View FENC research	View SRZN research